Ranibizumab in monotherapy and combined with photodynamic therapy for retinal angiomatous proliferation

PURPOSE: To compare the effects of intravitreal ranibizumab in monotherapy (group A) and combined with photodynamic therapy (PDT) with verteporfin (group B) in retinal angiomatous proliferation (RAP) treatment. METHODS: This was a multicentric, prospective, randomized clinical study conducted with p...

Descripción completa

Detalles Bibliográficos
Autores principales: Arias, Luis, Gómez-Ulla, Francisco, Ruiz-Moreno, José M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876105/
https://www.ncbi.nlm.nih.gov/pubmed/27274190
http://dx.doi.org/10.2147/OPTH.S106092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876105/
https://www.ncbi.nlm.nih.gov/pubmed/27274190
http://dx.doi.org/10.2147/OPTH.S106092

Ejemplares similares